AGER and central nervous system cancer: Consistent with the increased EC activation, we observed a significant increase in PBMC adhesion to ECs treated with CMs from oHSV-infected glioma cells that was rescued in the presence of RAGE antibody (2 μg/mL) and purified esRAGE (200 ng/mL) (Figure 2C).